BiomX (PHGE) Price to Earnings (2019 - 2026)
BiomX's (PHGE) quarterly Price to Earnings came in at 0.94 in Q2 2026, down 52.38% year-over-year from 1.97 in Q2 2025, and up 84.59% quarter-over-quarter from 0.51 in Q1 2026.
Analysis
BiomX (PHGE) Price to Earnings (2019 - 2026) Analysis & Trends
BiomX has disclosed Price to Earnings across 8 years of filings, most recently posting 0.94 for Q2 2026.
- In Q2 2026, Price to Earnings fell 52.38% year-over-year to 0.94; the TTM figure through Jun 2026 stood at 0.14 (up 114.09% YoY), while the FY2025 annual figure was 0.08, up 116.63% from the prior year.
- Price to Earnings came in at 0.94 for Q2 2026 at BiomX, up from 0.51 in the prior quarter.
- In the past five years, Price to Earnings ranged from a high of 4.39 in Q2 2023 to a low of 24.57 in Q2 2024.
- Average Price to Earnings over 5 years is 1.91, with a median of 0.47 recorded in 2023.
- Year-over-year, Price to Earnings soared 331.78% in 2023 and tumbled 659.06% in 2024.
- Over 5 years, Price to Earnings stood at 2.34 in 2022, then surged by 80.05% to 0.47 in 2023, then gained by 10.41% to 0.42 in 2024, then dropped by 24.12% to 0.52 in 2025, then jumped by 280.45% to 0.94 in 2026.
- Per Business Quant data, the three most recent Price to Earnings figures were 0.94 in Q2 2026, 0.51 in Q1 2026, and 0.52 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BiomX | 1.55 Mn | 7.73 Mn | 97,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.94 |
| Mar 31, 2026 | 0.51 |
| Dec 31, 2025 | -0.52 |
| Sep 30, 2025 | 1.54 |
| Jun 30, 2025 | 1.97 |
| Mar 31, 2025 | 1.81 |
| Dec 31, 2024 | -0.42 |
| Sep 30, 2024 | -3.66 |
| Jun 30, 2024 | -24.57 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | 3.48 |
| Jun 30, 2023 | 4.39 |
| Mar 31, 2023 | -3.75 |
| Dec 31, 2022 | -2.34 |
| Sep 30, 2022 | -1.50 |
| Jun 30, 2022 | -2.90 |
| Mar 31, 2022 | -7.03 |
| Dec 31, 2021 | -4.55 |
| Sep 30, 2021 | -8.60 |
| Jun 30, 2021 | -18.26 |